The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

To put this spike into perspective, the rural city of around 32,000 people has now recorded more HIV cases in two years than ...

Organizations that provide services like HIV education and living recommendations are being forced to cut programming after ...

Maine described its HIV outbreak as a significant health concern, but the shutdown has kept a CDC team from coming to the state's aid.

Congress’s bipartisan agreement to end the government shutdown restores operations across the federal government, but keeps major health programs, including the nation’s HIV response, ...

Local political activists put their heads together after first case of infection confirmed in 18-month-old girl.

WHO emphasizes integrating surveillance into national STI programs. Zoliflodacin, a novel antimicrobial agent, shows promise in treating gonorrhea, demonstrating non-inferiority to ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...